From Gestational Hypertension and Preeclampsia to Atypical Hemolytic Uremic Syndrome
- PMID: 27548541
- DOI: 10.1097/AOG.0000000000001610
From Gestational Hypertension and Preeclampsia to Atypical Hemolytic Uremic Syndrome
Comment in
-
In Reply.Obstet Gynecol. 2016 Sep;128(3):657-658. doi: 10.1097/AOG.0000000000001611. Obstet Gynecol. 2016. PMID: 27548542 No abstract available.
Comment on
-
From Gestational Hypertension and Preeclampsia to Atypical Hemolytic Uremic Syndrome.Obstet Gynecol. 2016 May;127(5):907-910. doi: 10.1097/AOG.0000000000001340. Obstet Gynecol. 2016. PMID: 27054930
References
-
- Tsai HM, Kuo E. From gestational hypertension and preeclampsia to atypical hemolytic uremic syndrome. Obstet Gynecol 2016;127:907–10.
-
- Burwick RM, Feinberg BB. Eculizumab for the treatment of severe preeclampsia/HELLP syndrome. Placenta 2013;34:201–3.
-
- Burwick RM, Burwick NR, Feinberg BB. Eculizumab fails to inhibit generation of C5a in vivo. Blood 2014;124:3502–3.
-
- Burwick RM, Fichorova RN, Dawood HY, Yamamoto HS, Feinberg BB. Urinary excretion of C5b-9 in severe preeclampsia: tipping the balance of complement activation in pregnancy. Hypertension 2013;62:1040–5.
-
- Vaught AJ, Gavriilaki E, Hueppchen N, Blakemore K, Yuan X, Seifert SM, et al. Direct evidence of complement activation in HELLP syndrome: a link to atypical hemolytic uremic syndrome. Exp Hematol 2016;44:390–8.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical